Basilea Pharmaceutica AG Stock
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe Europe
15:32:42 10/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 71.55 CHF | -0.90% |
|
-1.78% | +31.08% |
| Market Cap | 897M 1.09B 975M 814M 1.54B 102B 1.58B 10.73B 4.28B 54.81B 4.1B 4.01B 173B | P/E 2026 * |
12.7x | P/E 2027 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 730M 889M 793M 662M 1.26B 83.29B 1.29B 8.73B 3.48B 44.59B 3.34B 3.26B 140B | EV / Sales 2026 * |
2.48x | EV / Sales 2027 * | 2.36x |
| Free-Float |
91.78% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| BSLN | Delayed | |
London S.E.
| 0QNA | Delayed | |
|
CBOE
| 0QNA | Real-time | |
|
OTC Markets
| BPMUF | Delayed | |
|
Tradegate
| PK5 | Real-time | |
|
Deutsche Boerse AG
| PK5 | Delayed | |
|
Xetra
| PK5 | Delayed | |
|
Börse Stuttgart
| PK5 | Delayed | |
|
Boerse Muenchen
| PK5 | Real-time |
Last Transcript: Basilea Pharmaceutica AG
| 1 day | -0.90% | ||
| 1 week | -1.78% | ||
| Current month | +1.27% | ||
| 1 month | +9.13% | ||
| 3 months | +37.62% | ||
| 6 months | +30.13% | ||
| Current year | +31.08% |
| 1 week | 69.2 |  | 74.5 |
| 1 month | 64.4 | | 75.8 |
| Current year | 47.8 | | 75.8 |
| 1 year | 45.4 | | 75.8 |
| 3 years | 32 | | 75.8 |
| 5 years | 29.55 | | 75.8 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/05/26 | Sell | -400 | 0.0030% | |||
| 13/05/26 | Sell | -1,043 | 0.0078% | |||
| 04/05/26 | Sell | 400 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | -1.78% | +58.10% | +105.74% | 1.09B | |
| +2.24% | +8.40% | +58.47% | +69.00% | 68.22B | |
| +0.52% | +8.80% | +15.16% | +88.91% | 59.82B | |
| +0.61% | +1.87% | +24.42% | +98.57% | 56.07B | |
| +2.55% | +15.52% | +30.43% | +120.17% | 47.67B | |
| +2.58% | +7.89% | +32.49% | +45.30% | 45.95B | |
| +4.09% | +6.37% | +228.06% | +899.75% | 43.29B | |
| -0.47% | +9.38% | +27.53% | +52.40% | 35.66B | |
| +0.29% | -1.08% | +96.16% | +70.88% | 34.73B | |
| +1.48% | +6.21% | -38.80% | +395.73% | 25.47B | |
| Average | +1.30% | +7.03% | +53.20% | +194.64% | 42B | |
| Weighted average by Cap. | +1.59% | +7.82% | +53.78% | +183.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 294M 358M 320M 267M 506M 33.56B 518M 3.52B 1.4B 17.97B 1.34B 1.32B 56.59B | 283M 345M 308M 257M 487M 32.31B 499M 3.39B 1.35B 17.3B 1.29B 1.27B 54.48B |
| Net income | 68.7M 83.64M 74.66M 62.35M 118M 7.84B 121M 822M 328M 4.2B 314M 307M 13.22B | 64.41M 78.41M 69.99M 58.45M 111M 7.35B 114M 770M 307M 3.93B 294M 288M 12.39B |
| Net Debt | -167M -204M -182M -152M -288M -19.09B -295M -2B -798M -10.22B -764M -748M -32.19B | -230M -280M -250M -209M -396M -26.27B -406M -2.75B -1.1B -14.07B -1.05B -1.03B -44.3B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | CHF 71.70 | -0.69% | 4,027 |
| 09/11/26 | CHF 72.20 | +1.69% | 28,128 |
| 06/11/26 | CHF 71.00 | -0.56% | 25,815 |
| 05/11/26 | CHF 71.40 | -3.12% | 43,929 |
| 04/11/26 | CHF 73.70 | +0.96% | 52,743 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
